Transcript Slide 1

European Public Health Research &
Lifelong Physical Activity –
Increased Happiness For All?
Kevin McCarthy
Head of Sector Public Health
Directorate Health for Research & Innovation
European Commission
Seminar Lifelong Physical Activity – Increases Happiness for All?
South Finland EU Office 22 February 2011
1
EU Research Policy Competitiveness, Quality of Life
and Support to EU policies
The key objective of EU Research policy (Art. 173 of Lisbon Treaty):
“strengthening its (Union) scientific and technological bases by achieving
a European research area in which researchers, scientific knowledge and
technology circulate freely, and encouraging it to become more
competitive, including its industry“ and “while promoting all research
activities deemed necessary by virtue of other chapters of the
Treaties” (Art. 168 – public health)
The core objectives for Health research in FP7 are “improving the
health of the European citizens and increasing the competitiveness of
the European health related industries and businesses…” with emphasis
on “translational research”.
N.B.:
The European Commission currently manages about 5%
of total public spending in R&D in the European Union.
The EU currently invests about 1.9% of GDP in research
2
Role of EC in Research
European Commission programmes bring down barriers :
• between countries:
– multinational consortia (EU-27 + associated countries)
– researchers from any country in the world can participate;
and promotes coordination of national funding programmes (ERA)
• between different types of organizations:
universities, research centres, SMEs, large companies, etc.
• between disciplines: focus on translational research
and encourages mobility: Marie Curie fellowships for researchers
and for host institutes, including ingoing & outgoing grants
3
 Demand-driven
FP6 – SCIENTIFIC SUPPORT
TO POLICIES (SSP)
 Responsive to policy requirements:
 European Social Agenda - ageing,
combating discrimination, barrierfree Europe
 EU Public Health Programme –
monitoring, information, threats,
determinants
 Clients:
 DG SANCO, DG EMPL, DG ENV,
DG ECFIN, DG ENTR
 Budget: +/- 50 million €
4
“Health, Security and
Opportunities for the
People of Europe”
- Health determinants,
sustainable health care services and
pension systems (in particular in the
context of ageing and demographic
change) Area 2.1
- Public health issues • epidemiology,
disease prevention, rare and
communicable diseases, allergies,
secure blood and organ donations,
non-animal testing methods Area 2.2
5
FP6 SSP PROJECTS
• EUROCADET
Impact of key determinants on the current and
future burden of caner in Europe
• EURO-PREVOB
Tackling the social & economic determinants of nutrition
and physical activity for the prevention of obesity in Europe
• HOPE
Health-promotion through obesity prevention across Europe –
An integrated analysis to support european health policy
• AHEAD
Ageing, health status and determinants of health
expenditures
• SPHERE
Strengthening public health research in Europe
• MHADIE
Measuring health and disability in Europe: supporting
policy development
• EPIC
European prospective investigation into cancer, chronic
diseases, nutrition and lifestyle
6
EURO-PREVOB

Review the determinants of, and inequalities in, obesity in
Europe and policy initiatives to tackle obesity

Develop and pilot a tool to examine policies related to
obesity in Europe and to assess the food and built
environments that rich and poor people live in

Make recommendations to prevent obesity, especially
among those disadvantaged, and develop means to
evaluate the economics of policy options

Promote networking among different stakeholders
involved in nutrition, physical activity, obesity and
inequalities in obesity
7
EURO-PREVOB
conceptual framework
Economic operators
Government
Civil society
Socioeconomic
environment
and inequalities
Psychosocial and
cultural determinants
Food
Natural and
environment built environment
Individuals:
Energy
balance and
inequalities
in obesity
8
EURO-PREVOB
The built environment i.e. the ‘walkability’ and
‘bikability’ of affluent vs. deprived
neighbourhoods in terms of:
- the availability and quality of:
•
•
•
•
•
cycle lanes
public open spaces (including parks and playgrounds)
public transport stops
marked road crossings
sidewalks or pavements
- traffic volume
- evidence of ‘attractiveness / unattractiveness’
9
EURO-PREVOB recommendation:
a health-promoting built
environment should be created
• Government policies and initiatives should support
a health promoting natural and built environment,
taking into account the needs of low income and
other vulnerable groups.
• to support active transport such as walking and
cycling.
• access to local food markets can simultaneously
increase opportunities for healthy affordable food
options while supporting the local economy.
10
EURO-PREVOB research
recommendations - How to create
a health promoting natural and
built environment
Best approaches to improve behavioural
outcomes related to Physical Activity:
- Multi-component interventions (e.g. when targeting
children)
- Potential differential intervention effect on PA level
and relative body weight by socio-demographic
characteristics
- Impact of policy interventions on environmental
changes
11
2nd Programme of Community
Action in the field of Health
• DG SANCO – Operational Policy DG
• One of our clients – close collaboration
• Own programme to support public health
projects
• Information, Threats,
Health Systems, Determinants, Ageing
• EAHC - An Executive Agency for the public
health programme
• Does not support ‘research’
• Share many of the same ‘customers’ with
research
12
EU 7th Framework Programme
for Research (FP7) 2007-2013
The Health Theme in the
Cooperation Programme
13
Cooperation:
Collaborative research in FP7
Thematic Priorities
1.
2.
3.
4.
5.
6.
7.
8.
9.
Health
Food, agriculture, fisheries and biotechnology
Information and communication technologies
Nanosciences, nanotechnologies, materials
and new production technologies
Energy
Environment (including climate change)
Transport (including aeronautics)
Socio-economic sciences and the humanities
Security & 10. Space
Total for collaborative research
6.1
1.9
9.1
3.5
2.3
1.9
4.2
0.6
2.8
€32.4 billion
14
Health theme structure
Pillar 1:
Pillar 2:
Pillar 3:
Biotechnology,
generic tools
& technologies
for health
Translating
research for
human health
Optimising
the delivery
of health care
Cross-cutting issues: child health, the health of ageing population
gender-related health issues
Activity (Pillar) 4:
Specific International Cooperation
Actions (SICAs) and other actions
across the theme – EU policy needs
15
The Health Theme
Activity 3
3. Optimising the delivery of health care to citizens
… performing health policy-driven research at the European
level enables comparisons to be made of the models, systems,
data, and patient material held in national databases and
biobanks.
This activity aims at providing the necessary basis both for
informed policy decisions on health systems and for more
effective and efficient evidence-based strategies of health
promotion, disease prevention, diagnosis and therapy.
 Translating clinical research into clinical practice
 Health care systems research
 Health promotion and disease prevention
16
The Health theme
structure and content
3. Optimising the delivery of health care to citizens
 Translating clinical research into clinical practice behavioural and organisational interventions, patient safety,
better use of medicines, decision-making in clinical settings
 Quality, efficiency,solidarity of health care systems,
organisational, financial, regulatory aspects, best-good practice,
workforce
 Enhanced health promotion and disease prevention, wider
determinants of health, providing evidence of best public health
measures – life styles, interventions, mental health in a life
course perspective
17
Collaborative research
in the Health Theme
The Third Pillar:
 a completely new activity – health policy driven, informing policy
 aims at developing new research methods
• to generate a sound scientific basis
• to underpin informed policy decisions on health systems
• to achieve more effective and efficient evidence-based strategies
of health promotion, disease prevention, diagnosis and therapy
 in a context set by the overarching values of universality, access
to good health care, equity and solidarity aiming to make
provision that is patient-centred and responsive to individual
need
Users: EC, MS, WHO, OECD, clinicians, professionals, patients, other
stakeholders
18
109 EU FP7 Public Health
Research Projects - some 275+
million € in support
• Quality and safety of hospital care
• Healthy behaviour
• Child health research
• Child & adolescent mental health
• Long term care
• Primary care quality linkage to costs
• Health workforce – mobility & planning
• Health inequalities
• Urban health
19
Activity 3
Optimising the delivery of healthcare
to European citizens + SICAs
Support to Activity 3 after 4 Calls:
109 Projects 275 M€*
2007 – 2010 Budgets, 4th Calls to-date:
637.5M, 578.3M, 624.6M, 657,4M
Total of 2,497.8M€
5th Call – current one
Indicative budget of 662,5M
Activity 3 (+ SICAs) : 42M
* includes EU policy support projects
20
Activity 3
Optimising the delivery of healthcare
to European citizens + SICAs
Support to Activity 3 Calls 1-4*
109 Projects - 275 M€
3.1: Translating clinical research outcome into clinical
practice - 28 projects 67.5 million €
3.2: Health systems research - 26 projects 63.5 million €
3.3: Health promotion & disease prevention
- 20 projects 47 million €
3.4: International public health & health systems research
- 35 projects 97 million €
* includes EU policy support projects
21
Activity 3
Optimising the delivery of healthcare
to European citizens
SP Mandate 3.3:
Enhanced health promotion and disease prevention: to provide
evidence for the best public health measures in terms of life
styles, work and living circumstances and interventions at
different levels and in different contexts.
Focus will be on the wider determinants of health and how they
interact at both the individual and community level (e.g. diet,
stress, tobacco, alcohol and other substances, physical activity,
cultural context, socio-economic and environmental factors). In
particular, mental health will be addressed in a life-course
perspective.
22
23
Activity 3
Optimising the delivery of healthcare
to European citizens
http://ec.europa.eu/research/health/public-health/index_en.html
24
Building Bridges …..
25
• Building Bridges – what kind
• The Research – Policy Gap
• Knowledge transferbrokering
• Understanding the
translation – ‘translational
research’ …
• Fit for purpose ?
26
5th Call Topic on
translating research
into policy
HEALTH.2011.3.3-3*
Developing & implementing
methods for the transfer of
research into policy in the fields
of health promotion and disease
prevention
* Closed 10 November 2010
27
Influencing factors …
Increased focus on limited number of strategic
areas, innovation, SMEs, EU2020, ERA,
Innovation Partnerships – Health, Ageing
Joint programming – Alzheimer, ageing, diet
Specific programme coverage & cross-thematic
approaches
Socio-economic dimension
 EC policy services, FP projects …
Dissemination actions, brokerage
Post FP7 – programming …
28
Commission Recommendation
on Joint Programming for
"A Healthy Diet for a Healthy Life "
Adopted on 28/04 2010 C(2010)2587 final
Approved at Competitiveness Council of 26/05/2010
Strategic Research Agenda in formation
through a Management Board (national representatives)
29
JPI Proposal
Grand challenge
The grand challenge for Europe is to
reverse this situation; to shift from a
defensive policy combatting illness to an
offensive and preventing approach
promoting health
Societal / Medical / Economic
challenge
30
Three Programme Lines:
1)
JPI Proposal
Research questions
Lifestyle and social determinants
Consumer behaviour, determinants of food choice and life
styles, social and economic effects of public health
interventions, programmes, policies
2) Prevention of chronic diseases and health
maintenance :
Improve detection of common and distinct pathways
(mechanisms of inflammation, genetics susceptibility,
biomarkers etc.). Databases, registers, cohorts
3) Diet and food production – Comprehensive approach
New and advanced technologies for a comprehensive
approach- Targeted development of products and
processes
31
Current scientific issues
- Need for coordination
• Food and health research is a very complex field
• Need for advancing the understanding of the
interaction between food, nutrition, genetics, lifestyles
and health
• Need to develop advanced methods based on new and
cross-cutting technologies
• Need to develop advanced approaches and methods in
social sciences
• Information on the state of research in food and health
in Member States is fragmented and non-homogeneous
• Very few EU countries have developed an ‘integrated’
food and health programme
• Joint research programmes on food and health at
national level are more common
32
Influencing factors …
EU – Member States (n = 27)
Candidate/Accession countries
• Croatia
• Turkey
Countries associated with the FP
• Iceland
• Israel
• Norway
• Switzerland
33
Realising the Potential of
EU Public Health Research
• Working with other themes, actions within FP7 to identify
potential contributions – SSH, Env, Food, ERA-Nets, JP, Marie
Curie …
• Working with operational services of the Commission to
share/identify that potential – SANCO, EMPL, ENV, TRNSPORT,
MARKT, DEV, AIDCO also ECDC, EUROSTAT …
• Reaching out to stakeholders/communities to inform them of
such potential – MS, professionals, patients, policy-makers,
academia … through various fora
• Communicating/sharing project developments and results – but
more than dissemination
• Interacting at the international level – WHO, OECD …
34
5th Call Topic on
translating research
into policy
HEALTH.2011.3.3-3*
Developing & implementing
methods for the transfer of
research into policy in the fields
of health promotion and disease
prevention
Will focus on physical activity
* Closed 10 November 2010
35
Contacts:
Director – Ruxandra Draghia-Akli:
Scientific Adviser: Alain Vanvossel ([email protected])
Medical Research unit (F2)
Acting & Deputy Head of unit: Maria Vidal ([email protected])
Infectious Diseases and Public Health Research unit (F3)
Head of unit: Line Matthiessen-Guyader ([email protected])
Deputy Head of Unit Anna Lönnroth ([email protected])
Head of Sector Public Health: Kevin McCarthy ([email protected])
Genomics and Systems Biology unit (F4)
Head of unit: Patrik Kolar ([email protected])
Deputy Head of unit: Bernard Mulligan ([email protected])
Head of Sector Medicines for the Future: Irene Norstedt [email protected])
Health Biotechnology unit (F5)
Head of unit: Arnd Hoeveler ([email protected])
Coordination unit (F1)
Head of unit: Stéphane Hogan
([email protected])
Admin. & Finance unit (F6)
Head of unit: Georgios Zisimatos
([email protected])
36
Contacts & Information
SME participation Dr. Ludovica Serafini
Tel. +32 2 295 6759 – Email: [email protected]
International Cooperation Dr. Indridi Benediktsson
Tel. +32 2 299 3137 – Email: [email protected]
Framework Programme 7: http://cordis.europa.eu/fp7
Experts: http://cordis.europa.eu/research_openings/
NCP: http://cordis.europa.eu/fp7/get-support_en.html
37
Thank you !
EU – Member States (n = 27)
12 Countries associated with FP7
• Albania
• Bosnia Herzegovina
• Croatia
• FYR of Macedonia
• Iceland
• Israel
• Liechtenstein
• Montenegro
• Norway
• Serbia
• Switzerland
• Turkey
38